RxSight's LALs continue to dominate the cataract market with 80% YoY growth. Learn why RXST is a "buy" for investors seeking ...

Financials, energy, and crypto have been the biggest recent winners, which means that value has also been making a comeback. Even though defensive equities haven’t been signaling a notable risk ...